about
Hepatic arterial embolization in patients with neuroendocrine tumorsIn vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cellsTreatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.Predictive factors of response to mTOR inhibitors in neuroendocrine tumoursInterpreting biochemical control response rates with first-generation somatostatin analogues in acromegalyThe effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyThe Treatment of Cushing's Disease.Animal models of medullary thyroid cancer: state of the art and view to the futureInfluence of Bisphenol A on Type 2 Diabetes MellitusApplication of molecular biology of differentiated thyroid cancer for clinical prognosticationQuantitative and functional expression of somatostatin receptor subtypes in human thymocytesThe biological characterization of neuroendocrine tumors: the role of neuroendocrine markersHMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomasLow vitamin D status and obesity: Role of nutritionist.Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus.Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.An evaluation of patients with hyperprolactinemia: have dynamic tests had their day?Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal.Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.Hormonal and seminal evaluation of Leydig cell tumour patients before and after orchiectomy.The circulating level of FABP3 is an indirect biomarker of microRNA-1.Central diabetes insipidus and heart: effect of acute arginine vasopressin deficiency and replacement treatment with desmopressin on cardiac performance.Growth hormone and the heart.Fixity of vocal cords and laryngocele in acromegaly.Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter.Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures.Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells.Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.Real-world study of everolimus in advanced progressive neuroendocrine tumors.Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.Preliminary results demonstrating the impact of Mediterranean diet on bone health.Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome.Pegvisomant in acromegaly: an update.Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects.Hospitalizations in Pediatric and Adult Patients for All Cancer Type in Italy: The EPIKIT Study under the E.U. COHEIRS Project on Environment and HealthSomatostatin receptors in the thymus.Growth hormone and cardiac function.The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
P50
Q21198838-46770E9D-CABA-4F29-B862-47BEE1B5E40FQ22008658-C8F0F5AF-F586-47D5-A36E-81DEB8FCD4BBQ24629410-1E5520A7-3910-4F9C-8F6F-C4219A6B59F7Q26775959-2C8B5C05-192E-4E05-8903-824254744E92Q26777682-7846DE60-9D46-4674-B736-CDA34B9220CBQ26796357-7DF72327-BC5D-4ED3-B5FA-C7A52141B495Q27010590-0AD6D1BA-931F-4705-A8E9-DF46A95D3480Q28073423-3620AB06-A630-476C-9F85-DA68C4472406Q28075627-AD7302D5-7F6E-4125-9BDC-131CB46B123BQ28079198-151A63B0-5807-49B2-A4C7-F25D2EA277E8Q28206900-BB704CB4-C7E1-40A8-A016-BB27136D9C1CQ28275872-12563217-A337-4D58-B310-580538EFCC58Q28594353-D6270231-53C3-4A37-9A23-872C4FC30976Q30235602-070F3CA1-3B62-4081-89D0-4223BB60157AQ30248235-F1BDC30E-7309-4290-B1F8-0576265F85D5Q30581654-1CA11612-9F38-426F-90B3-96BEDE5E3FF1Q30873929-E555C194-912C-436E-8BCE-2437AD9596D9Q30883703-B36D1164-B5AA-42BA-A4E4-D75B32A37EC2Q31141613-151F9E52-7106-4804-B0C5-A8B7EF965604Q31157584-2A5A4942-5090-4F04-AFFE-909E42C6859BQ31397946-D2D264AC-3BAF-4D3E-95C2-C517B778677EQ31813056-07AEA24F-7DEE-43E6-94C9-D500F6325179Q31894251-C1162472-F5FD-4E73-A347-132E2F6DC892Q32026861-99B244B9-CA81-4428-827D-CE40F301AE41Q32103202-AF9443DC-F9BA-4319-93AF-79113AA24026Q33194943-CE451C22-5CB9-4537-AA3B-3BEF6C385E1EQ33271311-5E1F93D6-2228-4244-B1F1-9BEFED3DE2AFQ33337708-0A8E4CC4-E9F9-437F-9078-A21093848FA2Q33393235-E514423B-E1CD-49DF-B4C7-2CAD790BAE89Q33417013-948DE043-352B-4A93-B270-262073541FBEQ33579615-FD1A81EC-2B8E-4AC5-BE6F-06E29731919BQ33601154-314E024F-43C5-4F88-AC66-B48BF7C679ACQ33602108-812B5795-5651-4967-B32E-37A5D68072C0Q33645326-76445BDA-60B3-4DEA-9D86-7130C33E7D0DQ33725999-92D59FB0-5F38-43BA-BC0B-0E51CF74853CQ33739766-7773E41B-EBCA-4B1C-9C97-A30300BB573DQ33748647-66E51477-0911-4C27-9178-D9A73E0F6C30Q33780563-E0AC05CC-8FF5-446D-8B35-6E216038E371Q33903319-6DBC1A8A-53C8-4ABC-A5DB-74A002FE63D2Q33912655-7DD7CD56-2A35-45C2-93FD-0C0596999E22
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Annamaria Colao
@ast
Annamaria Colao
@en
Annamaria Colao
@es
Annamaria Colao
@nl
type
label
Annamaria Colao
@ast
Annamaria Colao
@en
Annamaria Colao
@es
Annamaria Colao
@nl
altLabel
A Colao
@en
A. Colao
@en
Colao A
@en
Colao A.
@en
Colao
@en
prefLabel
Annamaria Colao
@ast
Annamaria Colao
@en
Annamaria Colao
@es
Annamaria Colao
@nl
P214
P106
P21
P214
P31
P496
0000-0001-6986-266X
P7859
lccn-n2018184180